Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03687892
Other study ID # 39234
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date April 1, 2019
Est. completion date October 22, 2022

Study information

Verified date October 2023
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators plan to use functional magnetic resonance imaging (fMRI) methods to assess brain changes following spaced theta burst stimulation (TBS), a new form of repetitive transcranial magnetic stimulation (rTMS), in 10 healthy participants. The investigators will measure the effects of both excitatory (intermittent, iTBS) and inhibitory (continuous, cTBS) TBS applied to the motor cortex, a system that when stimulated produces a readily observable behavioral response (e.g., movement of a given body regions). In addition to brain activity, we will assess the effects of TBS on motor responses and pain perception. The goal is to determine how brain activity and blood flow during tasks and at rest change following the applications of spaced cTBS and iTBS. Additionally, the aim is to determine the duration of the spaced TBS effects on brain activity and behavior. This study will provide an understanding of the functional brain and behavioral changes that occur following spaced TBS to the motor cortex and has implications for reducing the long treatment schedules associated with classical rTMS protocols.


Description:

Overall study design: The investigators propose a functional MRI study of 10 healthy participants recruited from the community using a cross-over design over two days. On day 1, half of the participants will be randomized to receive iTBS and half will receive cTBS. On scan day 2 the alternate form of TBS will be applied such that all participants will have completed iTBS and cTBS sessions at the end of the two study days. MRI scan days 1 and 2 will be identical except that iTBS will be applied on one day and cTBS on the other. The duration of the MRI scan session will be approximately 120 minutes each day. The iTBS and cTBS scans sessions will be separated by at least 3 days to ensure that the effects of scan day 1 are not carried over to scan day 2. Each scan day will consist of the following sessions: 1. Pre-scan session 2. Baseline scan 3. TBS (individually targeted to M1) 4. Post-TBS scan Participants and Screening: 10 healthy individuals from the community will be recruited. Potential participants will be screened using the MRI Safety Screening Questionnaire, the Transcranial Magnetic Stimulation Adult Safety Screen (TASS), and the Mini Mental State Examination (MMSE) to exclude individuals with contraindications to MRI, TMS, or with cognitive impairments, respectively. Eligible participants will provide written informed consent. Experimental Design: Participants will be asked to refrain from taking any analgesic medication for 24 hours prior to scan days. At the start of each scan day, participants will first undergo a Pre-scan session outside of the scanner. In this session, baseline resting motor thresholds and pain thresholds to laser stimuli will be obtained. Participants will also have the opportunity to practice the motor and pain tasks that they will perform in the MRI sessions during this time. For the motor task participants will be asked to tap their finger when a verbal and/or auditory cue is provided. For the pain task, participants will passively experience and rate laser stimuli applied to different regions of the dorsum of their fingers/hands using a 0-10 numerical rating scale (NRS). Ratings will be made for both pain intensity and pain unpleasantness. On both scan days (iTBS and cTBS) baseline MRI scans will be acquired. These scans will include the following: a high-resolution anatomical scan, a resting-state scan, a motor task scan, a pain task scan, cerebral blood flow imaging, and an interleaved TMS-fMRI scan. Participants will then be removed from the scanner and receive a spaced TBS session (either iTBS or cTBS depending on the day) whereby 2 TBS protocols are applied with a 15 minute break in between. TBS will be applied at The stimulation will be delivered at 90% of the resting motor threshold. The brain region that will be targeted is the M1 region with the highest activity from the fMRI motor task that occurred in the baseline scan. In this way, each participant will receive TBS that is individually targeted based on their brain function. Following TBS, participants will then receive their post-TBS MRI scans as described in the baseline scan session. Study Specifics: rTMS administration: Using single pulse TMS the scalp position of lowest motor threshold for the right first dorsal interosseous or abductor pollicis brevis muscles will be determined. Resting motor threshold (rMT) will be defined by the lowest power setting producing a visible muscle contraction in 50% trials utilizing PEST software. The investigators will then perform 40 seconds of cTBS or iTBS (depending on the session), which will be followed by 15 minutes of spacing, and then an additional 40 seconds of cTBS or iTBS as has been previously described. The individualized TBS target location for the left M1 will be determined by using each participants' functional motor task MRI scan and Localite Neuronavigation. The baseline structural scan obtained during scan 1 will also be utilized for this localization process. Pain induction assessment procedures: On the scanning days, baseline warmth sensation threshold, heat-pain threshold (HPTpre) and suprathreshold stimulus intensities and maximum heat tolerance temperature (HTTpre) will be determined for each volunteer using an MRI-safe infrared diode laser stimulator. A 1.5 s, heating ramp up to 20 °C/s will be applied to 10-20 spots (40 mm2) on the hairy skin of the hand and fingers (but not the thumb) of participants. Pain threshold will be determined using a random staircase method of assessment. The average laser power necessary to produce a rating of "1" will be used to establish the pain threshold. To determine an intensity-effect relationship, pulses will then applied with increasing stimulus intensities to different areas of the dorsum of the hand/fingers with at least 30 s between stimuli. Subjects will be asked to rate the pain intensity and unpleasantness immediately after each stimulus (0 to 10, NRS). Stimulus intensities will be increased in 300 mW increments. Intensity increases will be continued until a given subject reports a level of moderate pain intensity (5 out of 10, NRS). This intensity will be considered "suprathreshold" for the scan studies. In order to train volunteers in rating their pain with an 11-point numerical rating scale (0 to 10, NRS), the temperature of the laser will then be set to evoke random skin temperatures for 5 s between the individual HPTpre and HTTpre separated by 30-s intervals, and the volunteers were asked to rate their pain. For scans after rTMS-augmented hypnotic analgesia or hypnotic analgesia alone (sham rTMS + hypnotic analgesia), heat pain scores evoked by the pre-established threshold and suprathreshold laser powers will be assessed following each scan. Decreased pain ratings will determine the strength of any analgesic effect TBS. Subjects will be asked to rate their laser-evoked pain following each stimulus during each scan. Physiologic data acquisition: Throughout the scanning procedure we will monitor peripheral autonomic physiology using MRI compatible EKG leads and a chest belt that monitors respiration. This will allow us to compute respiratory sinus arrhythmia, which provides a good estimate of vagal tone, which, in turn, is associated with better cardiac health and self-soothing. Customized algorithms developed here at Stanford for simultaneous fMRI/EEG to remove MRI scanner artifact from the EKG tracing will be applied. Brain Imaging Scans: 1. T1-weighted scan (high-resolution anatomical image) 2. Resting-state scan 3. BOLD motor-tapping task scan 4. Pain task scan 5. Arterial-spin labeling scan (cerebral blood flow) 6. Interleaved TMS-fMRI scan


Recruitment information / eligibility

Status Terminated
Enrollment 37
Est. completion date October 22, 2022
Est. primary completion date October 22, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 or older - Right-handed - Agree to having fMRI scan - Willingness to suspend use of analgesic drugs or cough suppressants for 24 hours prior to the scans - Proficiency in English sufficient to complete questionnaires/follow instructions during fMRI assessments - US Citizen or resident able to receive payment legally Exclusion Criteria: - A medical condition that would contraindicate the use of rTMS - Any condition that would contraindicate MRI (like ferromagnetic metal in the body) - Pregnancy or breast feeding - Any significant neurologic disease, including dementia, multi-infarct dementia, Parkinson's or Huntington's disease, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, history of significant head trauma - Current antidepressant use (must be washed out for two weeks prior to starting protocol) - Inability to stop taking medication contraindicated with treatment

Study Design


Related Conditions & MeSH terms


Intervention

Device:
continuous Theta Burst Stimulation
Continuous Theta Burst Simulation will be applied in a continuous manner resulting in cortical excitability.
intermittent Theta Burst Stimulation
Intermittent Theta Burst Stimulation will be applied in an intermittent manner resulting in cortical inhibition.

Locations

Country Name City State
United States Stanford University Palo Alto California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

References & Publications (38)

Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357-81. doi: 10.1146/annurev.ne.09.030186.002041. No abstract available. — View Citation

Baeken C, Marinazzo D, Everaert H, Wu GR, Van Hove C, Audenaert K, Goethals I, De Vos F, Peremans K, De Raedt R. The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging. Brain Stimul. 2015 Jul-Aug;8(4):808-15. doi: 10.1016/j.brs.2015.01.415. Epub 2015 Feb 7. — View Citation

Baeken C, Marinazzo D, Wu GR, Van Schuerbeek P, De Mey J, Marchetti I, Vanderhasselt MA, Remue J, Luypaert R, De Raedt R. Accelerated HF-rTMS in treatment-resistant unipolar depression: Insights from subgenual anterior cingulate functional connectivity. World J Biol Psychiatry. 2014 May;15(4):286-97. doi: 10.3109/15622975.2013.872295. Epub 2014 Jan 21. — View Citation

Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985 May 11;1(8437):1106-7. doi: 10.1016/s0140-6736(85)92413-4. No abstract available. — View Citation

Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J. Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci. 2004 Apr;19(7):1950-62. doi: 10.1111/j.1460-9568.2004.03277.x. — View Citation

Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J. Subthreshold high-frequency TMS of human primary motor cortex modulates interconnected frontal motor areas as detected by interleaved fMRI-TMS. Neuroimage. 2003 Nov;20(3):1685-96. doi: 10.1016/j.neuroimage.2003.07.028. — View Citation

Bohning DE, Shastri A, McConnell KA, Nahas Z, Lorberbaum JP, Roberts DR, Teneback C, Vincent DJ, George MS. A combined TMS/fMRI study of intensity-dependent TMS over motor cortex. Biol Psychiatry. 1999 Feb 15;45(4):385-94. doi: 10.1016/s0006-3223(98)00368-0. — View Citation

Bohning DE, Shastri A, Nahas Z, Lorberbaum JP, Andersen SW, Dannels WR, Haxthausen EU, Vincent DJ, George MS. Echoplanar BOLD fMRI of brain activation induced by concurrent transcranial magnetic stimulation. Invest Radiol. 1998 Jun;33(6):336-40. doi: 10.1097/00004424-199806000-00004. — View Citation

Cao G, Harris KM. Augmenting saturated LTP by broadly spaced episodes of theta-burst stimulation in hippocampal area CA1 of adult rats and mice. J Neurophysiol. 2014 Oct 15;112(8):1916-24. doi: 10.1152/jn.00297.2014. Epub 2014 Jul 23. — View Citation

Cardenas-Morales L, Gron G, Kammer T. Exploring the after-effects of theta burst magnetic stimulation on the human motor cortex: a functional imaging study. Hum Brain Mapp. 2011 Nov;32(11):1948-60. doi: 10.1002/hbm.21160. Epub 2010 Dec 22. — View Citation

Cazzoli D, Muri RM, Schumacher R, von Arx S, Chaves S, Gutbrod K, Bohlhalter S, Bauer D, Vanbellingen T, Bertschi M, Kipfer S, Rosenthal CR, Kennard C, Bassetti CL, Nyffeler T. Theta burst stimulation reduces disability during the activities of daily living in spatial neglect. Brain. 2012 Nov;135(Pt 11):3426-39. doi: 10.1093/brain/aws182. Epub 2012 Jul 24. — View Citation

Chouinard PA, Van Der Werf YD, Leonard G, Paus T. Modulating neural networks with transcranial magnetic stimulation applied over the dorsal premotor and primary motor cortices. J Neurophysiol. 2003 Aug;90(2):1071-83. doi: 10.1152/jn.01105.2002. Epub 2003 Apr 17. — View Citation

Duprat R, Desmyter S, Rudi de R, van Heeringen K, Van den Abbeele D, Tandt H, Bakic J, Pourtois G, Dedoncker J, Vervaet M, Van Autreve S, Lemmens GM, Baeken C. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission? J Affect Disord. 2016 Aug;200:6-14. doi: 10.1016/j.jad.2016.04.015. Epub 2016 Apr 19. — View Citation

Eldaief MC, Halko MA, Buckner RL, Pascual-Leone A. Transcranial magnetic stimulation modulates the brain's intrinsic activity in a frequency-dependent manner. Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21229-34. doi: 10.1073/pnas.1113103109. Epub 2011 Dec 12. — View Citation

Fox P, Ingham R, George MS, Mayberg H, Ingham J, Roby J, Martin C, Jerabek P. Imaging human intra-cerebral connectivity by PET during TMS. Neuroreport. 1997 Aug 18;8(12):2787-91. doi: 10.1097/00001756-199708180-00027. — View Citation

George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE 3rd, Schwartz T, Sackeim HA. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010 May;67(5):507-16. doi: 10.1001/archgenpsychiatry.2010.46. — View Citation

George MS, Taylor JJ, Short EB. The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry. 2013 Jan;26(1):13-8. doi: 10.1097/YCO.0b013e32835ab46d. — View Citation

George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallett M, Post RM. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 1995 Oct 2;6(14):1853-6. doi: 10.1097/00001756-199510020-00008. — View Citation

Goldsworthy MR, Pitcher JB, Ridding MC. Neuroplastic modulation of inhibitory motor cortical networks by spaced theta burst stimulation protocols. Brain Stimul. 2013 May;6(3):340-5. doi: 10.1016/j.brs.2012.06.005. Epub 2012 Jul 5. — View Citation

Goldsworthy MR, Pitcher JB, Ridding MC. Spaced Noninvasive Brain Stimulation: Prospects for Inducing Long-Lasting Human Cortical Plasticity. Neurorehabil Neural Repair. 2015 Sep;29(8):714-21. doi: 10.1177/1545968314562649. Epub 2014 Dec 11. — View Citation

Goldsworthy MR, Pitcher JB, Ridding MC. The application of spaced theta burst protocols induces long-lasting neuroplastic changes in the human motor cortex. Eur J Neurosci. 2012 Jan;35(1):125-34. doi: 10.1111/j.1460-9568.2011.07924.x. Epub 2011 Nov 25. — View Citation

Holtzheimer PE 3rd, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, Epstein CM. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety. 2010 Oct;27(10):960-3. doi: 10.1002/da.20731. — View Citation

Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6. doi: 10.1016/j.neuron.2004.12.033. — View Citation

Koch G, Bonni S, Giacobbe V, Bucchi G, Basile B, Lupo F, Versace V, Bozzali M, Caltagirone C. theta-burst stimulation of the left hemisphere accelerates recovery of hemispatial neglect. Neurology. 2012 Jan 3;78(1):24-30. doi: 10.1212/WNL.0b013e31823ed08f. Epub 2011 Dec 14. — View Citation

Larson J, Lynch G. Induction of synaptic potentiation in hippocampus by patterned stimulation involves two events. Science. 1986 May 23;232(4753):985-8. doi: 10.1126/science.3704635. — View Citation

Larson J, Munkacsy E. Theta-burst LTP. Brain Res. 2015 Sep 24;1621:38-50. doi: 10.1016/j.brainres.2014.10.034. Epub 2014 Oct 27. — View Citation

Li CT, Chen MH, Juan CH, Huang HH, Chen LF, Hsieh JC, Tu PC, Bai YM, Tsai SJ, Lee YC, Su TP. Efficacy of prefrontal theta-burst stimulation in refractory depression: a randomized sham-controlled study. Brain. 2014 Jul;137(Pt 7):2088-98. doi: 10.1093/brain/awu109. Epub 2014 May 10. — View Citation

Liston C, Chen AC, Zebley BD, Drysdale AT, Gordon R, Leuchter B, Voss HU, Casey BJ, Etkin A, Dubin MJ. Default mode network mechanisms of transcranial magnetic stimulation in depression. Biol Psychiatry. 2014 Oct 1;76(7):517-26. doi: 10.1016/j.biopsych.2014.01.023. Epub 2014 Feb 5. — View Citation

Nettekoven C, Volz LJ, Kutscha M, Pool EM, Rehme AK, Eickhoff SB, Fink GR, Grefkes C. Dose-dependent effects of theta burst rTMS on cortical excitability and resting-state connectivity of the human motor system. J Neurosci. 2014 May 14;34(20):6849-59. doi: 10.1523/JNEUROSCI.4993-13.2014. — View Citation

Nyffeler T, Cazzoli D, Hess CW, Muri RM. One session of repeated parietal theta burst stimulation trains induces long-lasting improvement of visual neglect. Stroke. 2009 Aug;40(8):2791-6. doi: 10.1161/STROKEAHA.109.552323. Epub 2009 Jun 11. — View Citation

Nyffeler T, Wurtz P, Luscher HR, Hess CW, Senn W, Pflugshaupt T, von Wartburg R, Luthi M, Muri RM. Extending lifetime of plastic changes in the human brain. Eur J Neurosci. 2006 Nov;24(10):2961-6. doi: 10.1111/j.1460-9568.2006.05154.x. — View Citation

Orosz A, Jann K, Wirth M, Wiest R, Dierks T, Federspiel A. Theta burst TMS increases cerebral blood flow in the primary motor cortex during motor performance as assessed by arterial spin labeling (ASL). Neuroimage. 2012 Jul 2;61(3):599-605. doi: 10.1016/j.neuroimage.2012.03.084. Epub 2012 Apr 12. — View Citation

Pascual-Leone A, Valls-Sole J, Wassermann EM, Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain. 1994 Aug;117 ( Pt 4):847-58. doi: 10.1093/brain/117.4.847. — View Citation

Siebner HR, Peller M, Willoch F, Minoshima S, Boecker H, Auer C, Drzezga A, Conrad B, Bartenstein P. Lasting cortical activation after repetitive TMS of the motor cortex: a glucose metabolic study. Neurology. 2000 Feb 22;54(4):956-63. doi: 10.1212/wnl.54.4.956. — View Citation

Siebner HR, Takano B, Peinemann A, Schwaiger M, Conrad B, Drzezga A. Continuous transcranial magnetic stimulation during positron emission tomography: a suitable tool for imaging regional excitability of the human cortex. Neuroimage. 2001 Oct;14(4):883-90. doi: 10.1006/nimg.2001.0889. — View Citation

Speer AM, Willis MW, Herscovitch P, Daube-Witherspoon M, Shelton JR, Benson BE, Post RM, Wassermann EM. Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: II. Effects of prefrontal cortex rTMS. Biol Psychiatry. 2003 Oct 15;54(8):826-32. doi: 10.1016/s0006-3223(03)00324-x. — View Citation

Suppa A, Huang YZ, Funke K, Ridding MC, Cheeran B, Di Lazzaro V, Ziemann U, Rothwell JC. Ten Years of Theta Burst Stimulation in Humans: Established Knowledge, Unknowns and Prospects. Brain Stimul. 2016 May-Jun;9(3):323-335. doi: 10.1016/j.brs.2016.01.006. Epub 2016 Jan 27. — View Citation

Watanabe T, Hanajima R, Shirota Y, Ohminami S, Tsutsumi R, Terao Y, Ugawa Y, Hirose S, Miyashita Y, Konishi S, Kunimatsu A, Ohtomo K. Bidirectional effects on interhemispheric resting-state functional connectivity induced by excitatory and inhibitory repetitive transcranial magnetic stimulation. Hum Brain Mapp. 2014 May;35(5):1896-905. doi: 10.1002/hbm.22300. Epub 2013 Jul 29. — View Citation

* Note: There are 38 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Motor Evoked Potential To determine the duration of effect of an application of a spaced TBS stimulation session (both inhibitory, cTBS and excitatory, iTBS) as measured by duration of change in motor evoked potential. Prior to and and immediately after TBS sessions on each day (separated by 3+ days)
Secondary Change From Baseline Resting-state Functional Connectivity Between the M1 Hotspot and Other Motor Areas Immediately Post-TBS To determine the resting state functional connectivity changes that result from an application of spaced TBS stimulations (both inhibitory, cTBS and excitatory, iTBS). Prior to and and immediately after TBS sessions on each day (separated by 3+ days)
Secondary Change From Baseline Motor Cortex Activity as Assessed by the BOLD Signal Immediately Post-TBS To determine the TMS-BOLD (over M1) changes that result from an application of spaced TBS stimulations (both inhibitory, cTBS and excitatory, iTBS). Prior to and and immediately after TBS sessions on each day (separated by 3+ days)
Secondary Changes in Arterial Perfusion To determine the arterial perfusion changes that result from an application of spaced TBS stimulations (both inhibitory, cTBS and excitatory, iTBS) as measured by ASL. Prior to and and immediately after TBS sessions on each day (separated by 3+ days)
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1